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Abstract The mixed lineage kinase (MLK) family is a recently
described protein kinase family. The MLKs contain a kinase
domain followed by a dual leucine zipper-like motif. We
previously reported the molecular cloning of LZK (leucine
zipper-bearing kinase), a novel MLK, and that LZK activated
the c-Jun NH2 terminal kinase (JNK)/stress-activated protein
kinase (SAPK) pathway through MKK7 in cells. Here, we reveal
that LZK forms dimers/oligomers through its dual leucine zipper-
like motif, and that this is necessary for activation of the JNK/
SAPK pathway. We also identify the C-terminal functional
region of LZK, which is indispensable for the activation of
SEK1, but not that of MKK7. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Mitogen-activated protein kinase (MAPK) pathways are
one type of the most important intracellular signal transduc-
tion pathways transmitting extracellular stimuli to the nuclei
of cells [1^5]. Each MAPK pathway consists of at least three
protein kinase components, MAP kinase, MAPK kinase
(MAPKK), and MAPKK kinase (MAPKKK). Upon activa-
tion, MAPKKK phosphorylates and activates MAPKK, and
then MAPKK phosphorylates MAPK, followed by nuclear
translocation of the activated MAPK. This leads to alteration
of the expression patterns of speci¢c subsets of genes, making
cells appropriately respond to extracellular stimuli. The c-Jun
NH2 terminal kinase (JNK) pathway is one of the MAPK
pathways, and is activated when cells are exposed to proin-
£ammatory cytokines such as tumor necrosis factor-K and
interleukin-1, and extracellular stresses such as UV irradiation
and osmotic shock [6^10]. As with other MAPK pathways,
this pathway consists of MAPK (JNK), MAPKKs (MKK7
and SEK1/MKK4), and a variety of MAPKKKs including
MEKK1 (mitogen-activated protein or extracellular signal-
regulated protein kinase kinase kinase 1) [11], transforming
growth factor-L-activated kinase 1 [12], ASK1 (apoptosis sig-
nal-regulated kinase 1) [13], and mixed lineage kinase family
protein kinases (MLKs) [14^18]. The MLKs comprise a re-
cently described protein kinase family consisting of MLK1,
2 and 3 [19^21], MAPK-upstream kinase (MUK)/dual leucine
zipper-bearing kinase (DLK) [14,22], and leucine zipper and
sterile K motif kinase [23]. Kinases in this family share struc-
tural features such as a kinase catalytic domain, which con-
tains the characteristic amino acid sequences of both serine/
threonine kinase and tyrosine kinase, followed by a dual leu-
cine zipper-like motif.
We previously reported the molecular cloning of a novel
MLK, LZK (leucine zipper-bearing kinase), from the human
brain [24]. LZK shows serine/threonine kinase activity and
activates the JNK pathway when overexpressed in cells, but
the molecular mechanism underlying MAPKK activation by
LZK remains unclear. As dimerization/oligomerization is be-
lieved to be necessary for activation of the downstream
MAPK pathway by many MAPKKKs including MLKs [25^
27], we here examined the signi¢cance of dimer/oligomer for-
mation by LZK as to its signal transduction.
In this study, we ¢rst reveal that LZK forms dimers/oligo-
mers through its dual leucine zipper-like motif. Next, we dem-
onstrate the functional signi¢cance of the dimerization/oligo-
merization. Furthermore, we identify the unique and essential
region for the downstream MAPKK activation by LZK.
2. Materials and methods
2.1. Plasmids, antibodies and reagents
To construct a mammalian expression vector for hemagglutinin
(HA)-tagged LZK, a fragment encoding the His-tag of pcDNA His-
LZK was replaced by a fragment encoding a HA epitope tag. To
construct an expression vector for a mutant LZK which lacks a
dual leucine zipper-like motif, pcDNA His-LZK vZip, the cDNA
fragment of LZK encoding amino acids 1^431, was ampli¢ed by poly-
merase chain reaction and then inserted into the NheI^BamHI
fragment of pcDNA His-LZK. The oligonucleotides used were; 5P-
TAATACGACTCACTATAGGG-3P and 5P-GATTGGATCCCTTC-
TCTCCATTCAGCCTGAGACT-3P, as sense and antisense primers,
respectively. The expression vector for kinase-negative LZK was con-
structed by site-directed mutagenesis, AAG being converted into
GCG, which resulted in substitution of lysine 195 with alanine. As
lysine 195 is most likely an ATP binding residue, LZK K195A was
expected to be a kinase-negative mutant [28]. The sequence of the
oligonucleotide used was 5P-GAGGTGGCCATCGCGAAAGTGA-
GA-3P. The mismatched nucleotides for mutagenesis are underlined.
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The expression construct pcDNA His-LZK, and pSRK HA-JNK,
pSRK Myc-MKK7, pSRK Myc-SEK1 and pEF MEKK1vN were
described previously [12,24,29,30]. The Escherichia coli expression
construct for glutathione S-transferase (GST)-c-Jun (1^79) was kindly
provided by Dr. Masahiko Hibi (Osaka University, Japan). The ex-
pression constructs for His-tagged serial deletion mutants of LZK and
GST kinase-negative JNK will be described elsewhere (Ikeda et al.,
submitted for publication).
Anti-His antibodies were purchased from Qiagen. Anti-Myc, anti-
HA and anti-MEKK1 were from Santa Cruz, and anti-Flag was from
Sigma. Anti-phosphorylated JNK was from Promega.
2.2. Cell culture and transfection
COS7 cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% heat-inactivated fetal calf serum and kanamy-
cin. For transfection, cells were subcultured and grown overnight, and
then transiently transfected with various expression constructs using
LipfectAMINE (Gibco BRL) according to the manufacturer’s proto-
col. After 24 h, the cells were lysed and then the lysates were subjected
to immunoprecipitation or directly to Western blotting as described in
the ¢gure legends.
2.3. Immunoprecipitation and Western blotting
Cells transiently transfected with various plasmids were lysed in cell
Fig. 1. LZK forms dimers/oligomers in cells. A: His-tagged LZK and its deletion mutants used in this study are schematically represented.
B: HA-LZK was expressed with or without His-LZK in COS7 cells, and His-LZK was immunoprecipitated from each cell lysate. The presence
of HA-LZK and His-LZK in the immunoprecipitate was examined by Western blotting with anti-HA or anti-His antibodies, respectively (top
and middle). The expression of HA-LZK in cells was examined by Western blotting (bottom). C: Serial C-terminal deletion mutants of LZK
were co-expressed with HA-LZK, followed by immunoprecipitation and Western blotting as in B. The representative results of three indepen-
dent experiments are shown. The speci¢c bands corresponding to LZKs are indicated by asterisks. D: His-LZK FL or His-LZK vZip was co-
expressed with HA-LZK, followed by immunoprecipitation and Western blotting as in B.
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lysis bu¡er (20 mM Tris/HCl, pH 7.5, 150 mM NaCl, 2 mM EGTA,
25 mM L-glycerophosphate, 50 mM sodium £uoride, 10% glycerol,
1% Triton X-100, 1 mM sodium vanadate, 1 mM phenylmethylsul-
fonyl £uoride, and 10 Wg/ml leupeptin). After centrifugation, the clari-
¢ed lysates were subjected to immunoprecipitation for 2 h at 4‡C. The
beads were washed three times with lysis bu¡er, and twice with wash
bu¡er (Tris-bu¡ered saline, pH 7.5, 0.05% Tween 20, and 1 mM
dithiothreitol), and then the absorbed proteins were solubilized with
sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) sample bu¡er. Western blotting was carried out as described
previously [24].
2.4. In vitro kinase kinase assay
Cells were transfected with expression plasmids, as indicated in the
¢gure legends. After 24 h, cell lysates were prepared and JNK, MKK7
and SEK1 activity was measured by means of in vitro kinase assay as
described elsewhere (Ikeda et al., submitted for publication). Brie£y,
each kinase was immunoprecipitated from cell lysate prepared as
above, and kinase reactions were carried out by incubating immuno-
precipitates with kinase reaction bu¡er containing 1 WCi of [Q-32P]ATP
and either 3 Wg of GST-c-Jun (1^79) (JNK assay) or 5 Wg of GST-
KN-JNK (MKK7 or SEK1 assay) for 20 min at 30‡C. Reactions were
terminated by the addition of SDS^PAGE sample bu¡er. Proteins
were resolved by SDS^PAGE and then the phosphorylated substrate
was visualized using a phosphorimage analyzer Fuji BAS2000.
3. Results and discussion
To determine whether or not LZK forms dimers or oligo-
mers in cells, we performed a co-immunoprecipitation assay.
HA-tagged LZK was co-expressed with His-tagged LZK in
COS7 cells, followed by immunoprecipitation with anti-HA
antibodies, and the co-immunoprecipitated His-tagged LZK
was detected by Western blotting with anti-His antibodies as
the primary antibodies. As shown in Fig. 1B, HA-LZK was
co-immunoprecipitated with His-LZK, indicating that LZK
forms homo-dimers or oligomers in cells. Similar results
were observed when anti-HA was used for immunoprecipita-
tion and anti-His for Western blotting.
Next, we examined the functional region in the LZK mol-
ecule which is responsible for the dimerization/oligomeriza-
tion, by means of a similar assay using a series of His-tagged
Fig. 2. C-terminal deletion mutant LZKs are incapable of activation of JNK. A: Serial deletion mutants of LZK were co-expressed with HA-
JNK, and at 24 h post-transfection, the cells were lysed by the addition of SDS^PAGE sample bu¡er, and then the amount of dually phos-
phorylated JNK was examined by Western blotting with anti-phosphorylated JNK antibodies (top). After the antibodies have been stripped o¡
the membrane, the same membrane was reprobed with anti-HA antibodies to examine the total amount of overexpressed JNK in each transfec-
tion (second from the top). The JNK activity was also measured by in vitro kinase assay with GST-c-Jun (1^79) as a substrate (third from the
top). In a parallel experiment, the amount of LZK in each lysate was determined by Western blotting with anti-His antibodies (bottom). The
representative results of three independent experiments are shown. B: His-LZK FL or His-LZK vZip was co-expressed with HA-JNK in cells,
followed by Western blotting as in A.
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LZK deletion mutants, as shown in Fig. 1A. All the mutants
containing a dual leucine zipper-like motif were co-immuno-
precipitated with full length HA-tagged LZK (Fig. 1C, lanes
2^4). On the other hand, LZK (1^431), a mutant that lacks
the dual leucine zipper-like motif, failed to be co-immunopre-
cipitated e⁄ciently with LZK FL (lane 5), although a faint
but reproducible signal was observed. Densitometric analysis
of the data revealed that the amount of co-immunoprecipi-
tated LZK (1^431) was about 13% that of LZK (1^558), when
normalized to the amounts of HA-LZK in the anti-HA im-
munoprecipitates, which were almost identical among the ex-
periments (data not shown). This suggests that the dual leu-
cine zipper-like motif was necessary for LZK to form dimers/
oligomers e¡ectively. To con¢rm this, we repeated this assay
using a deletion mutant, His-LZK vZip, which lacks the ami-
no acids 432^555 corresponding to the dual leucine zipper-like
of the LZK molecule. His-LZK vZip also failed to be co-
immunoprecipitated e¡ectively with HA-LZK (Fig. 1D), sug-
gesting again strongly that LZK forms homo-dimers/oligo-
mers via the dual leucine zipper-like motif. As LZK binds
to a sca¡old protein, JIP-1, via its N-terminal region contain-
ing the kinase catalytic domain (A. Ikeda et al., submitted for
publication), the region necessary for dimerization/oligomeri-
zation is distinct from the JIP-1 binding region.
Knowing that LZK forms dimers or oligomers, we next
investigated the functional signi¢cance of the dimer/oligomer
formation. First we examined whether or not each of these
LZK deletion mutants activates JNK. Full length or a mutant
LZK was co-expressed with HA-JNK in COS7 cells, and then
the cells were lysed at 24 h post-transfection. The amount of
activated JNK in each cell lysate was determined by Western
blotting with anti-phosphorylated JNK as the primary anti-
bodies. The JNK activity was also measured by in vitro kinase
assay with GST-c-Jun (1^79) as a substrate. The in vitro ki-
nase assay gave essentially the same results as those of the
Western blot with anti-phosphorylated JNK antibodies (see
Fig. 2A). As expected, full length LZK remarkably activated
JNK [24] (Fig. 2A, lane 2). However, to our surprise, all the
C-terminal deletion mutants failed to activate JNK like the
kinase-negative mutant LZK (LZK K195A), even though they
were able to form dimers/oligomers when co-expressed with
full length LZK (Fig. 2A, lanes 3^6, see also Fig. 1C). Mutant
LZKs were expressed in the transfected cells properly (Fig.
2A, bottom panel). Among these deletion mutants, the one
that contained the largest C-terminal portion lacked only 166
amino acid residues from the C-terminal end (amino acids
801^966). This region contains the 14 amino acid stretch of
unknown function, which is conserved in LZK and MUK/
DLK [24].
LZK vZip, which contains the C-terminal end region but
fails to form dimers/oligomers, was also completely unable to
activate JNK (Fig. 2B), indicating that dimerization/oligome-
rization is indispensable for LZK to activate the JNK path-
way.
Therefore, dimer/oligomer formation is the primary require-
ment for activation of the JNK pathway by LZK and the C-
terminal end region (amino acids 800^966) of LZK also par-
ticipates in the activation of the JNK pathway. These results
led us to examine why these C-terminal deletion mutant LZKs
failed to activate JNK. We next investigated whether or not
LZK (1^800) activates two distinct MAPKKs of the JNK
pathway, MKK7 and SEK1. His-LZK FL or His-LZK (1^
800) was co-expressed with either Myc-tagged MKK7 or
SEK1, followed by in vitro MAP kinase kinase assay using
GST kinase-negative JNK (GST-KN-JNK) as a substrate. In
both experiments, MEKK1vN (a constitutive active form of
MEKK1) was used as a positive control for MAPKKK. As
shown in Fig. 3A, both LZK FL and LZK (1^800) activated
MKK7 e⁄ciently. However, LZK (1^800) failed to activate
SEK1 even though LZK FL considerably activated it (Fig.
Fig. 3. The C-terminal region of LZK is indispensable for the activation of SEK1, but not that of MKK7. A: His-tagged LZK FL, LZK (1^
800), or MEKK1vN was co-expressed with Myc-MKK7. 24 h after transfection, the cells were lysed and Myc-MKK7 was immunoprecipitated
from the cell lysate, and then the kinase activity of MKK7 was determined by in vitro MAP kinase kinase assay using GST-KN-JNK as the
substrate (top). The amounts of overexpressed Myc-MKK7, His-LZKs, and MEKK1vN were determined by Western blotting (middle and bot-
tom). B: His-tagged LZK FL, LZK (1^800), or MEKK1vN was co-expressed with Myc-SEK1 in cells. SEK1 activity, and the amounts of
Myc-SEK1, His-LZKs and MEKK1vN were determined as in A.
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3B, upper panel; compare lanes 2 and 3). The amounts of
expressed MKK7 or SEK1 were almost identical in the lysate
(middle panels). These results indicate that the C-terminal end
of LZK is essential for the activation of SEK1 MAPKK, but
not for that of MKK7 MAPKK. As shown in Fig. 2A, lane 3,
LZK (1^800) failed to activate JNK, but it e⁄ciently activated
MKK7 (Fig. 3A), which is indicative of an activation of the
JNK pathway. The reason for this apparent discrepancy is
currently not clear. However, it should be noted that the assay
conditions used were di¡erent between these two experiments:
MKK7 was overexpressed in the Fig. 3A experiment, but only
endogenous MKK7 was present in the Fig. 2 experiment.
For MUK/DLK, the MLK that exhibits the highest se-
quence similarity with LZK, the dual leucine zipper-like motif
itself is enough for the formation of homo-dimers/oligomers
[26]. This suggests that the corresponding region of LZK is
similarly necessary for the formation of homo-dimers/oligo-
mers. MUK/DLK forms hetero-dimers/oligomers with LZK
less e⁄ciently than homo-dimers/oligomers, suggesting the
presence of an interaction between these two MLKs in vivo
[26]. However, it is likely that the N-terminal region rather
than the dual leucine zipper-like motif mediates the interac-
tion between LZK and MUK/DLK, as the leucine zipper
region of MUK/DLK was not co-immunoprecipitated with
LZK [26]. The facts that LZK is expressed in most of human
organs, with some variation in the amount [24], and on the
other hand MUK/DLK is a brain-speci¢c protein [14,22],
suggest that LZK forms homo-dimers or oligomers in some
tissues.
For some MAPKKKs such as ASK1 [31] and MLK3 [25],
dimerization is believed to be essential for e⁄cient signal
transduction to the downstream MAPKKs. Our results
strongly suggest that dimerization or oligomerization is also
indispensable for LZK to activate the JNK pathway. MLK3
and MUK/DLK are believed to form disul¢de-linked homo-
dimers/oligomers [25,26,32], but we could not clarify in this
study whether or not LZK forms disul¢de bridged dimers/
oligomers.
In addition to the dual leucine zipper-like motif as the di-
merization/oligomerization domain, the C-terminal end region
of LZK has been identi¢ed as an essential region for the
activation of SEK1/MKK4 but not that of MKK7. As men-
tioned above, this region contains the 14 amino acid sequence
completely conserved in LZK and MUK/DLK. To our
knowledge, this is the ¢rst report suggesting the possible
role of this sequence.
Therefore, LZK includes distinct functional regions such as
the JIP-1 binding region within or before the N-terminal re-
gion of its kinase catalytic domain, a dual leucine zipper-like
motif as the dimerization/oligomerization domain, and a
SEK1-activating region at its C-terminal end (see Fig. 4).
These results provide important clues as to how the kinase
activity of LZK or other MLKs is regulated in vivo.
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